Portola Pharmaceuticals Announces Commercial Supply Agreement For Andexanet Alfa With Lonza

By: via Benzinga
Portola Pharmaceuticals (Nasdaq: PTLA) today announced that it has executed a supply agreement with Lonza for the commercial ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.